Catalyst Pharmaceuticals (CPRX) Interest Coverage Ratio (2012 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Interest Coverage Ratio of 10.19 for Q1 2026, down 97.78% on a QoQ basis from 458.12 in Q4 2025, and down 7.53% year-over-year from 11.02 in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 10.19 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 7.53% year-over-year to 10.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 37.25 (down 7.44% YoY) and the FY2025 annual result came in at 8.44, up 34.5% from the prior year.
- Interest Coverage Ratio was 10.19 for Q1 2026 at Catalyst Pharmaceuticals, down from 458.12 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 758.04 in Q4 2023 and bottomed at 83.7 in Q4 2022.
- A 5-year average of 113.58 and a median of 10.19 in 2026 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 1644.47% in 2022, while the deepest fall reached 152.55% in 2022.
- Catalyst Pharmaceuticals' Interest Coverage Ratio stood at 83.7 in 2022, then surged by 1005.68% to 758.04 in 2023, then retreated by 11.81% to 668.54 in 2024, then sank by 31.48% to 458.12 in 2025, then slumped by 97.78% to 10.19 in 2026.
- Business Quant data shows CPRX's Interest Coverage Ratio at 10.19 in Q1 2026, 458.12 in Q4 2025, and 11.52 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 10.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.19 |
| Dec 31, 2025 | 458.12 |
| Sep 30, 2025 | 11.52 |
| Jun 30, 2025 | 11.53 |
| Mar 31, 2025 | 11.02 |
| Dec 31, 2024 | 668.54 |
| Sep 30, 2024 | 6.61 |
| Jun 30, 2024 | 7.04 |
| Mar 31, 2024 | 3.52 |
| Dec 31, 2023 | 758.04 |
| Sep 30, 2023 | -1.10 |
| Jun 30, 2023 | 1.38 |
| Mar 31, 2023 | 1.05 |
| Dec 31, 2022 | -83.70 |
| Sep 30, 2022 | 28.99 |
| Jun 30, 2022 | 5.76 |
| Mar 31, 2022 | 32.34 |
| Dec 31, 2021 | 159.28 |
| Sep 30, 2021 | 13.52 |
| Jun 30, 2021 | 29.49 |